Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)

This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A pharmaceutical composition that contains these new tetrahydrocarbazole derivatives as well as a process fo...

Full description

Saved in:
Bibliographic Details
Main Authors Koppitz, Marcus Karl, Muhn, Hans Peter, Shaw, Kenneth Jay, Hess-Stump, Holger, Paulini, Klaus
Format Patent
LanguageEnglish
Published 17.10.2006
Online AccessGet full text

Cover

More Information
Summary:This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A pharmaceutical composition that contains these new tetrahydrocarbazole derivatives as well as a process for the production of the new tetrahydrocarbazole derivatives are also provided. Moreover, this invention relates to the administration of tetrahydrocarbazole derivatives for treating pathologic conditions that are mediated by GPCR, especially for inhibiting GnRH, in mammals, especially humans, who require such an administration, as well as the use of tetrahydrocarbazole derivatives for the production of a pharmaceutical agent for treating GPCR-mediated pathologic conditions, especially for inhibiting GnRH.